127 related articles for article (PubMed ID: 9407952)
1. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.
Kerangueven F; Noguchi T; Coulier F; Allione F; Wargniez V; Simony-Lafontaine J; Longy M; Jacquemier J; Sobol H; Eisinger F; Birnbaum D
Cancer Res; 1997 Dec; 57(24):5469-74. PubMed ID: 9407952
[TBL] [Abstract][Full Text] [Related]
2. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
5. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
[TBL] [Abstract][Full Text] [Related]
7. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.
Kerangueven F; Eisinger F; Noguchi T; Allione F; Wargniez V; Eng C; Padberg G; Theillet C; Jacquemier J; Longy M; Sobol H; Birnbaum D
Oncogene; 1997 Jan; 14(3):339-47. PubMed ID: 9018120
[TBL] [Abstract][Full Text] [Related]
9. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
13. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.
Shivapurkar N; Sood S; Wistuba II; Virmani AK; Maitra A; Milchgrub S; Minna JD; Gazdar AF
Cancer Res; 1999 Aug; 59(15):3576-80. PubMed ID: 10446964
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells.
Charafe-Jauffret E; Moulin JF; Ginestier C; Bechlian D; Conte N; Geneix J; Adélaïde J; Noguchi T; Hassoun J; Jacquemier J; Birnbaum D
Int J Oncol; 2002 Nov; 21(5):989-96. PubMed ID: 12370745
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer.
Osborne RJ; Hamshere MG
Cancer Res; 2000 Jul; 60(14):3706-12. PubMed ID: 10919637
[TBL] [Abstract][Full Text] [Related]
19. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.
Noviello C; Courjal F; Theillet C
Clin Cancer Res; 1996 Sep; 2(9):1601-6. PubMed ID: 9816339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
